Use of one or more classes of medications for secondary CVD prevention peaked at 43.1 percent, decreased to 31.3 percent ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback